The effects of pregnancy on the flux of lead from maternal bone were investigated in five females from a unique colony of cynomolgus monkeys (Macaca fascicularis) which had been dosed orally with lead (approximately 1100-1300 /ig Pb/kg body wt) throughout their lives (about 14 years). Through the use of stable lead isotopes ^Pb, ^Pb, and ^Pb, it was possible to differentiate between the lead contributed to blood lead from the skeleton and the lead contributed from the current oral dose. Blood samples and bone biopsy samples taken before, during, and after pregnancy were analyzed for lead (total and stable isotope ratios) by thermal lonization mass spectrometry. Through the use of end-member unmixing equations, the contribution to blood of lead from maternal bone during pregnancy was estimated and compared to the contribution of lead from maternal bone before pregnancy. A 29 to 56% decrease in bone lead mobilization in the first trimester was followed by an increase in the second and third trimesters, up to 44% over baseline levels. In one monkey, the third-trimester increase did not reach baseline levels. In a single low-lead monkey, a similar decrease in the first trimester was followed by a 60% increase in the third trimester, indicating that a similar pattern of flux is seen over a wide range of lead concentrations. Analysis of maternal bone and fetal bone, brain, liver, and kidneys confirmed a substantial transplacental transfer of endogenous lead. Lead concentrations in fetal bone often exceeded maternal bone lead concentrations. From 7 to 39% of the lead in the fetal skeleton originated from the maternal skeleton, o 1977 society of Toxicology.
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Lead is a ubiquitous metal that continues to be of significant public health concern despite decades of study and regu-' This work was supported by NIEHS Contract NO1-ES-O5285 to Dr. Franklin. 2 To whom correspondence and reprint requests should be addressed at Pest Management Regulatory Agency, D716,2250 Riverside Drive, Ottawa, Ontario K1A OK9, Canada. lation worldwide. Approximately 90% of the body burden of lead in adult humans is in the skeleton (Barry, 1975) , where it becomes incorporated into the crystal matrix of bone (MacDonald et al, 1951; Aufderheide and Wittmers, 1992; Durbin, 1992) . Bone is not an irreversible "sink" for lead (Rabinowitz et al, 1976; Manton, 1977) , although the residence time for lead in bone is of the order of decades (Nielsson et al, 1991) . Pregnancy, lactation, menopause, osteoporosis, and certain disease states affect bone turnover. It has been suggested that they may also be associated with increased mobilization of lead from the skeleton, producing higher blood lead levels (Silbergeld, 1991; Silbergeld et al., 1988; Goyer et al, 1994) .
Lead crosses the placenta (Barltrop, 1969) , resulting in approximately equal concentrations of lead in maternal blood and fetal cord blood (Bellinger et al, 1987) . The high sensitivity of the fetus to the toxic effects of lead has been ascribed to the poorly developed blood:brain barrier (Goyer, 1990) and to the potential susceptibility of the developing nervous system during early structuring and modification of the neuronal circuitry (Regan et al, 1989) . Hence, a greater understanding of the mobilization of lead from bone to blood during pregnancy is desirable (Mushak, 1993; Franklin et al, 1995) . It is particularly important to ascertain how much lead may become available during pregnancy and whether it is derived from endogenous or exogenous sources in order to implement appropriate mitigative measures.
Early work by Rabinowitz et al (1976) and Manton (1977) demonstrated that through the use of stable lead isotope markers and thermal ionization mass spectrometry (TIMS), it is possible to measure the isotopic components of lead in a mixture and thereby identify the source of the lead. Stable lead isotope measurements may also be used to investigate whether changes in maternal blood lead levels during pregnancy are related to a rise in bone lead mobilization, to dietary sources, or to a combination of the two. We had access to a cohort of cynomolgus monkeys that had been dosed with lead for about 10 years prior to the start of our study. In this study, through the use of sequential administration of different stable lead isotopes (Inskip et al., 1996) , it has been possible to maintain five of the females on their lead dosing regime during pregnancy and to investigate (1) whether there was an increase in mobilization of lead from maternal bone during pregnancy, (2) how much lead from the maternal bone reached the fetus, and (3) what markers of maternal exposure are appropriate for predicting in utero exposure.
METHODS

Animal History and Care
The study animals were eight physically healthy, mature adult female cynomolgus monkeys (Macaca fascicularis) weighing between 3 and 6 kg and housed at the Health Protection Branch (Ottawa, Ontario, Canada). Five monkeys (designated CF131, CF145, CF158, CF162, and CF175) with elevated blood lead concentrations (30-67 jig/100 g) had been raised in captivity from birth (Rice et al., 1990) and ranged from 11 to 13 years old at the time of pregnancy. Two unexposed animals (CF123 and CF177) with low blood lead (<5 /ig/100 g), treated as controls, were also raised in the facility from birth and were 13 and 10 years at the time they conceived. These low-lead animals were used only for comparisons of typical fetal tissue concentrations with those observed in this study. A feral animal (C83659F) with a low blood lead concentration (< 1 /ig/100 g) and a history of brief exposure to lead with a distinct isotopic fingerprint several years previously had been housed in the facility since 1983 and was at least 14 years old at the time of pregnancy. Because this low-lead animal had a distinct bone lead isotopic fingerprint, it was possible to treat it in the same way as the five high-lead monkeys.
All animals were housed singly and maintained according to national guidelines (Canadian Council on Animal Care, 1984) . This included regular exercise programs and environmental enhancement schemes. All toys and play materials were tested/certified for low lead. The animals were fed a modified and certified diet 3 containing 1% calcium, 2 I.U. of Vitamin DV g, and a lead content of less than 0.2 /xg/g dry wt. Fresh water of known low lead content was provided ad libitum.
Study Design
The eight adult female monkeys were followed before pregnancy, after mating with non-lead-dosed male monkeys, and throughout the pregnancy and early postpregnancy period. Delivery was by cesarian section at about gestation day 150. During the study period, sequential samples were taken from five high-lead animals and one low-lead animal for measurement of blood lead concentration and stable lead isotope ratios. Maternal bone biopsies were taken before pregnancy and just after cesarian section for measurement of lead concentrations and isotope ratios, and fetal blood and tissues, including the whole skeleton, were collected at delivery and analyzed for lead concentration and isotope ratios.
Prior to our custody, the lead dosed monkeys had been dosed 5 days per week with a nominal 2100 ^g/kg/day, equivalent to 1500 fig/kg/day for each of 7 days a week (Rice, 1990) . Dosing started from birth or from age 300 days. The isotopic signature was confirmed to be that of common lead (Inskip et al., 1996) . To maintain the steady state that was assumed to exist, we continued to administer this relatively high dose, but the frequency of dose administration was changed to 7 days per week with the appropriate adjustment to maintain the same time-weighted average dose. The daily lead dose was given as a self-administered capsule. On days when blood samples were required, dose administration was delayed until after collection, so that the time interval since the previous dose ingestion was approximately 24 hr. This interval was somewhat variable due to differences in the monkeys' individual capsule-ingestion habits. Lead dosing solutions with modified isotopic compositions were prepared by combining isotopically enriched (""Pb, ^Ph, or ''"Pb) lead acetate trihydrate 4 with the common lead acetate salt. 3 The times at which the doses were switched and the number of times switches occurred for each particular monkey are shown in Fig. I . Test analyses confirmed distinct isotopic fingerprints or signatures, with only minor differences in lead concentration among the different solutions (1072 to 1261 /ig/kg body wt) as measured by thermal ionization mass spectrometry. Dosing solutions were color coded to ensure correct allocation to animals. Further details and verification of the method for sequentially dosing monkeys with enriched isotope solutions as a means of identifying fluxes of lead from bone to blood have been previously reported (Inskip et al., 1996) .
The isotopic signature of lead in bone of the low-lead animal C83659F was enriched in ""Pb as a result of dosing, for a 4-month period in 1990, with
2O4
Pb acetate trihydrate (nominally 1500 /jg Pb/kg/day). Analysis 3 years later confirmed that the lead present in the animal's bone and blood still strongly reflected this unique isotopic fingerprint. The animal received only small amounts of environmental lead during pregnancy, mostly through microcontaminant levels in the food.
Control animals were exposed only to environmental lead. Any lead present in blood and tissues would have originated from the diet or from environmental sources having a common lead isotopic fingerprint.
The lead-dosed animals were switched on May 31st 1993 from lead with a common signature to lead with an enriched "'Pb signature. Duration of administration and sequence of the different unique isotope mixes varied between animals depending upon the time elapsed before each animal conceived. Early in pregnancy, a switch to a different lead isotope was carried out (Fig. 1) . Approximately 4 weeks after cesarian section, controlled lead administration was terminated and the monkeys were subsequently maintained on a placebo capsule containing only glycerol.
Using standard surgical procedures, 6 cesarian section took place at approximately gestation day 150, just prior to normal gestation in this species which ranges from 155-180 days (Tarantal and Gargosky (1995) . Under deep anaesthesia, the fetus was transferred to a Class-100 clean room and euthanized by exsanguination via the left ventricle. The first blood sample extracted, using an ultraclean disposable polyethylene pipet, was weighed into a Teflon container for later analysis. Samples of fetal brain, liver, kidney, and femur were also taken at this time in accordance with the procedures described below.
Sampling Techniques
Scrupulous measures were taken to ensure that tissue samples were not contaminated with lead from the environment and that cross-contamination between animals did not occur (Inskip et al., 1992 (Inskip et al., , 1996 .
3 Purina Monkey Chow type 5047; PMI Foods, Richmond, IN.
4 Martin Marietta Energy Systems Inc., Oak Ridge, TN. 5 Aldrich Chemical Co., Milwaukee, WI. 6 Surgical procedures carried out were: (i) Bone biopsy: surgery included antibiotic prophylaxis, premedication with glycopyrrolate (0.015 mg/kg, im), immobilization with ketamine hydrochloride (10 mg/kg, im), and then intubation and maintenance on isoflurane gas. The analgesic Buprenorphine was administered postoperatively (0.01 mg/kg). (ii) Caesarian section: surgery included premedication, immobilization, and intubation and maintenance on isoflurane gas with doses as described for the biopsy surgery. Hemostasis was achieved after removal of the fetus and placenta, and, on closure, the uterus and abdomen were flushed with Penbritin. Postoperative administration included Buprenorphine (0.01 mg/kg) and Ethacillin (25 mg/ kg for 7 days). Blood sampling. Prior to pregnancy, blood samples (0.5 to 1 ml) were drawn from the saphenous vein every 2 weeks or less frequently when the animals were being mated to avoid stress during this critical period. After shaving and extensive washing of the skin, the blood sample was drawn into Teflon PFA containers 7 and processed under Class-100 air, HEPA filtered in accordance with procedures outlined by Everson and Patterson (1980) . Blood sampling continued during pregnancy, with approximately four samples taken in each 55-day period: early pregnancy (0-55 days), mid-pregnancy (56-110 days), and late pregnancy (111-150 days). Addi-7 Savillex Corporation, Minnetonka, MN. tional sampling (two to four samples) took place after delivery, including at the time of the postpregnancy bone biopsy, 14 days after cesarian section.
Bone biopsy procedures. The proximal and distal tibia were selected due to site accessibility and the presence of both trabecular and cortical bone. Small samples, approximately 50 mg, were obtained with a 2-mmdiameter trephine. Using standard surgical techniques, 6 a prepregnancy distal tibial biopsy was taken after the animals had been dosed with ^Pb, followed by a contralateral sample (distal tibia) 2 weeks following cesarian section. Similar sampling was carried out on the low-lead animal, which confirmed the ^Pb-enriched signature in its skeleton. The biopsy samples were meticulously cleaned to remove all nonosseous material, using ultrapure water and ultrafine dissecting tools under a binocular microscope Downloaded from https://academic.oup.com/toxsci/article-abstract/39/2/109/1641229 by guest on 20 January 2019 (Manea-Kritchen et al., 1991) . After separation into cortical and trabecular components and cleaning with glass-distilled acetone and ultrapure deionized water, samples were dried at 25°C under vacuum to provide "marrowfree dry bone."
Fetal bone and tissue sampling. Sample preparation for fetal tissues and blood (Inskip et al., 1992 ) was based on methods described by Patterson and Settle (1976) . Ultraclean sampling procedures and stainless steel instruments were used to obtain samples of fetal brain, liver, kidney, and femur. After preliminary defleshing of the remaining whole fetal skeletons, long bones and ribs were cut open longitudinally and further defleshed using (a) a dermestid beetle colony (Hefti et al., 1980) and (b) boiling distilled water, and (c) acetone and ultrapure water to provide marrow-free dry bone. The whole marrow-free dry fetal skeleton was weighed and dissolved in ultrapure acid, and an aliquot was treated as described below for lead analysis by TIMS.
Analysis of Total Lead and Isotope Ratios
All chemistry was conducted under Class-100 air. Samples were analyzed by the conventional silica-gel technique on a multicollector Finnegan-MAT 261 thermal ionization mass spectrometer. Details of the analyses have been given previously (Inskip et al., 1996) . The specific modifications to traditional chemistry techniques required by the high organic content of the samples are described in Manton and Edwards (1997) . Lead was separated from high-lead blood samples and all bone samples using standard HBr-HC1 ion-exchange columns (Manhes et al., 1978) . Lead was separated from low-lead blood samples using a standard ion-exchange column initially followed by a single-resin-bead extraction (Manton, 1978) . Total chemistry blanks were <200 pg for the double column procedure and <100 pg for single-bead extraction including the initial column separation. Reproducibility based on multiple analyses of an isotopic lead standard (National Institute of Standards and Technology (NIST), NBS 981) was <0.05% per atomic mass unit (amu). Relative standard deviations for total lead concentration and isotopic composition were estimated at 1% or better and 0.2% or better, respectively, for blood samples, and 0.07 and 0.05% or better, respectively, for bone samples, based on duplicate analyses of a NIST blood standard (SRM 955a) and an in-house bone standard. Isotopic ratios have not been corrected for mass fractionation because the extent of mass fractionation in the spectrometer for biological samples is unknown. No isotopic standard for blood is available to allow us to assess fractionation effects. The extent of fractionation for NBS 981 was 0.13%/amu. Results are expressed as /ig/ g of marrow-free dry bone or fig Pb/100 g blood. Conversion of blood lead concentrations to /ig/100 ml can be accomplished by multiplying by 1.031, die density of monkey blood, and conversion to /imol/L by multiplying by 0.049.
Data Reduction Process
The total lead concentration and isotope ratios of the blood and bone samples were unmixed by using end-member unmixing equations (Inskip et al., 1996) that give die proportion of total lead derived from each dose (i.e., the common lead, ""Pb-enriched, ^"Pb-enriched, and ^"Pb-enriched doses). Using analogous unmixing equations, the quantity of lead in the whole fetal skeleton that had originated from die maternal bone was determined, as well as the quantity of lead that had originated from the lead dose administered during pregnancy. Adult skeletal weight as a proportion of total body weight of the dams was obtained from studies carried out using cynomolgus monkeys (Durbin et al., 1996) . The total skeletal lead content of the dam was calculated from the concentrations of lead measured in the tibia] bone biopsies and the estimated skeletal weighL
RESULTS
Lead Levels in Maternal Blood
Bone lead contribution to total blood lead of nonpregnant monkeys. At the start of the experiment, when the animals had been dosed only with common lead, the isotopic composition of blood lead was an indistinguishable mixture of common lead absorbed from the gut and common lead returned from soft tissues and bone. Once the oral dosing solution was switched from common lead to enriched lead (^Pb, ^Pb, or ^"Pb), the oral contribution to blood lead had a different isotopic fingerprint from that of the bone and soft tissues. This isotope switching allowed the behavior of the endogenous lead to be studied despite the continuing presence of lead absorbed from the gut, since the only source of common lead in the blood was the soft tissues and bones.
As shown in Fig. 2 , when monkey CF158 was switched from common lead to a dosing solution enriched in 2O4 Pb, the total blood lead concentration remained in the same range while the common lead concentration dropped from a high of 36.8 Mg/100 g 1 day after the switch to 9.0 /ig/100 g at day 29. After this initial rapid decline of common lead, primarily from soft tissues, the remaining source of common lead in blood was bone and the concentration of common lead declined very gradually to 4.5 /xg/100 g by day 99. All the monkeys showed similar patterns of elimination/ mobilization with common lead. As observed in a previous study (Inskip et al., 1996) , a similar pattern of elimination/ mobilization was observed for those animals where the dose was switched a second time.
In order to estimate the mobilization of lead in pregnancy for each monkey, a baseline (nonpregnant) average contribution of lead from bone to blood was calculated for the 55-day period prior to pregnancy. The prepregnancy bone-derived lead ranged from 3.8 to 17.6 //g/100 g, or from 12 to 30% of total blood lead, in the five high-lead monkeys (Table  1) . For low-lead monkey C83659F, 82.5% of total blood lead was attributable to bone lead (Table 1) .
Bone lead contribution to total blood lead of pregnant monkeys. When the monkeys were confirmed as pregnant (at approximately day 30 of pregnancy), the dosing solution was switched to a new isotope. An average lead concentration for each trimester was calculated for each animal using all the sample values measured in the trimester (Figure 3 and Table 1 ). Compared to the prepregnancy baseline, the contribution of lead from bone to blood decreased by up to 56% in the first trimester in all animals with the exception of CF145. Although the mean value for this animal showed no decrease, the sequential blood lead data (Figure 3) are nevertheless suggestive of a delayed decrease, perhaps linked to consequences of the unusually elevated total blood lead (91 ^.g/100 g) for the first-trimester period, which is approximately three times that of the other animals. A rebound occurred in the second trimester for all of the animals, with bone lead contributions to blood lead exceeding baseline values in four of five high-lead animals as well as in the sixth, low-lead animal (Table 1) . The bone lead contribution was about the same in the third trimester as in the second " Prepregnancy = day -55 to day 0. The period corresponding to the 3rd trimester is shorter than other pregnancy periods due to the requirement to perform the C-section at GD 150/151. GD 165 is often taken as average gestation length.
* Measurement for 1st trimester may slightly underestimate bone contribution; it does not include the rapid turnover of recently deposited lead in bone originating from the currently administered lead dose.
trimester. The similarity in the patterns of change between low-lead monkey C83659F, whose blood lead is comparable to levels currently typical for humans (Manton and Angle, 1995) and the high-lead monkeys (Fig. 3) indicates that the pattern of mobilization of bone lead is similar over a wide range of blood lead levels.
If estimates of endogenous contribution to blood lead are expressed as a percentage of total blood lead (Manton, 1985; Gulson et ai, 1995) when the total blood lead level is low, the bone contribution will appear high. The contribution of bone lead to blood lead in monkey C83659F is comparable to the upper range of estimates made recently for adult humans: 70% (Manton, 1985) , 30-65% (Smith et ai, 1995) , and 41-73% (Gulson et al, 1995) . However, in the leaddosed animals maintained at a high blood lead level over their lifetime, the large oral dose is the overwhelming contributor to blood lead. In these animals, the percentage contribution of bone lead to total blood lead is much lower despite the fact that the absolute amount of lead contributed from bone is up to 37 times greater than in the low-lead animal (up to 17.6 /ig/100 g vs 0.47 ^g/100 g).
Oral lead contribution to maternal blood lead. Appearance in the blood of isotopically labelled lead administered during pregnancy allows us to gain information on possible changes in G.I. tract absorption/excretion. Table 2 shows the mean blood lead values attributable only to the oral lead " Prepregnancy = Day -58 to Day 0; Period corresponding to 3rd trimester is shorter than other pregnancy periods due to requirement to perform C-Section at GD 150/151. GD 165 is often taken as average gestation length. Postpregnancy = one measurement at 12-18 days after C-Section. doses (or diet) received by the dams while pregnant (i.e., excluding the endogenous component of total blood lead coming from lead in bone). In three of the five lead-dosed monkeys, there was an increase in orally derived blood lead over the trimesters of pregnancy. This is illustrated in more detail for one animal in Fig. 2 . In the low-lead animal C83659F, there was also some suggestion of a small increase in late pregnancy (Fig. 4) , although the contribution was minor in comparison to that coming from bone. There is some supportive evidence for a similar nonuniform response in human pregnancy (Manton and Angle, 1995; Rothenberg et ai, 1994) , although the blood lead data obtained in these studies did not allow the investigators to distinguish between the dietary and bone lead components.
Lead Accumulation in the Fetus
Blood lead. Blood lead concentrations in the fetus were very similar to those of the mothers except in monkey CF145, where fetal blood lead was lower (Table 3 ). The explanation for the disparity in this one animal is not immediately apparent. However, the proportion of the blood lead concentration attributable to each dose is similar between the mother and the fetus (common = 23.7% vs 22.1 %, ^Pb = 7.4% vs 6.9%, and ^Pb = 68.9% vs 71.0%). Despite the difference in total blood lead, this indicates that bidirectional transfer also occurred for CF145, as in the other maternal/ fetal pairs.
Bone lead. The amount of lead in fetal bone originating from the mother's bone ranged from 7 to 25% in the leaddosed animals and was 39% in the low-lead monkey (Table  4 ). The remaining lead in the fetal skeleton was attributable to the oral dose ( 206 Pb or 207 Pb) received by the mother during pregnancy.
Homogeneity in isotopic composition and lead concentration throughout the fetal skeleton was observed in each of two fetuses whose skeletons were subdivided for separate analysis into skull, limbs, spinal column, and ribs (data not shown).
In order to estimate the net transfer of lead to the fetus, the weight of the entire fetal skeleton, its lead content, and that of the maternal bone were determined. Using measurements relating maternal bone mass to body weight (Durbin et ai, 1996) the mean total lead content of the maternal skeleton was estimated to be 22.7 mg for the lead-dosed animals. The measured total lead content of the fetal skeleton averaged 1.81 mg. From this information, the sequential isotope method allowed us to calculate the net transfer of lead from the mother's bone to the fetal bone, which averaged 0.31 mg lead. This was approximately 1.3% of her total bone lead or 5.1% of her trabecular bone lead. The corresponding values for the low-lead animal (C83659F) were 1.1% of her total bone lead and 2.4% of her trabecular bone lead.
Soft tissues. Total concentrations of lead in the soft tissues of fetuses from mothers that had never been dosed with lead (CFI23 andCF177) or had received only transient doses (C83659F) were very low (Table 5) . Comparably low values of lead have been found in samples of brain tissue from control rats using a similar TIMS analytical technique (Frederickson et al, 1982) . Liver, kidney, and brain lead concentrations of fetuses from lead-dosed monkeys in this study were approximately two orders of magnitude higher in the high-lead monkeys than those in the low-lead monkeys. The high accumulation in the brain may be attributable to the immaturity of the blood:brain barrier during fetal development. 
DISCUSSION
Until recently, the time course of blood lead levels during human pregnancy has not been well defined. A recent detailed study of blood lead in 105 Mexican women (Rothenberg et al, 1994) involved serial measurements during pregnancy. The results were suggestive of a small decline in early pregnancy followed by a slightly larger rise in late pregnancy. Although bone lead status was not known, it was reasonably assumed that endogenous stores would be contributory to the blood lead increase. Another recent report has shown a similar trend over the course of pregnancy (Schuhmacher et al, 1996) . Preliminary data from Manton and Angle (1995) showed up to a 50% increase in maternal blood lead from mid-pregnancy to delivery in approximately half of the women studied.
While there is some evidence of bone lead mobilization from experimental animal studies (Bhattacharyya, 1983) , there are comparatively few studies in humans. The most instructive information has tended to come from detailed studies of individuals (Manton, 1985 (Manton, , 1992 Thompson et al, 1985) . Manton (1977 Manton ( , 1992 followed blood lead (total and stable isotope ratios) in two women during pregnancy. The blood lead concentration doubled in one of the women and changes in the isotopic ratios indicated that bone was the source of the lead. In the second case, there was only a minimal change in concentration. Although Ernhart and Green (1992) have questioned the explanation of increased bone lead mobilization for the rise in blood lead, the available evidence suggests that some, but not necessarily all women have an increased flux of lead from bone to blood during pregnancy (Manton, 1992; Manton and Angle, 1995) . A significant advantage of the current study in monkeys is that bone biopsies were performed to obtain specific data on the isotopic composition of the bone and blood compartments, allowing the contribution of bone lead to blood lead to be evaluated more directly. The concentration of bone-derived lead in maternal blood decreased by a mean of about 36% in the first trimester. Factors such as hemodilution and increased organ weights presumably contributed to this decrease. Lead from bone contributed to the increase in maternal blood lead seen in late pregnancy. In fact, five of the six monkeys had a greater absolute contribution of bone lead to blood lead in the third trimester of pregnancy than before they were pregnant. In the low-lead monkey, the increase was very small and did not materially affect the total blood lead concentration of less than 1 /xg/100 g. In the high-lead monkeys, it contributed as much as an additional 3 //gs of lead/100 g of blood, illustrating the importance of the lead exposure history as a determinant of the impact of bone lead on blood lead during pregnancy.
In all the monkeys, gestation day 60 (approximately equivalent to week 17-18 in humans) appeared to be the time point at which the bone lead contribution began to increase after the initial decline. Given the difference in gestation time between species, this is close to the "point of transition" (20 weeks) in the human study (Rothenberg et ai, 1994) between the early decline and subsequent rise in blood lead. As observed in studies of the chronology of fetal skeletal development in a closely related macaque (Macaca mulatto), this period (55-60 days) corresponds to the earliest appearance of ossification centers (van Wagenen and Asling, 1964) . This is the time at which calcium and, by inference, other bone-seeking elements like lead are laid down in mineralized bone during the fetal bone-modeling process. Unfortunately, prepregnancy blood levels for the women in Rothenberg's study were not known, so it is not possible to determine whether their blood levels were higher at delivery than they were prior to pregnancy, as was the case for all six monkeys in this study.
Some monkeys (Fig. 2 ) also showed an increased oral lead contribution to blood lead during pregnancy, with an indication that this occurred somewhat later (about midterm) than the changes due to bone lead contributions. This increase, however, was not consistent across animals in the study group. Consequently, the results of this study suggest that a combination of endogenous and exogenous factors, including the magnitudes of past and current lead exposure, can affect maternal blood lead in pregnancy. Even with the controlled lead exposure regimen in these monkeys and their Measurements of skeletal weight of 18 cynomolgus monkey fetuses (g dry wt) at different gestational ages (includes controls, leadexposed, stillborn, and aborted fetuses assessed as being of normal body weight for their gestational age). The line represents a least squares, power series fit, Y = X 46 ". similarity in age, the prepregnancy contribution of bone lead to blood lead was quite variable (17.6 /ig/100 g for CF145 vs 4 /zg/100 g for CF158). When differences in fractional absorption of lead from the GI tract are taken into account as well, the existence of a wide range of blood lead profiles should not be surprising. There are indications, from preliminary results emerging from a current study of human pregnancy, that the same may be true for individual human subjects (Manton and Angle, 1995) . It is interesting to note that the peak maternal blood lead concentration did not necessarily occur at day 150 (Fig. 3) , so that use of lead levels in cord blood at delivery to gauge exposure to the fetus throughout pregnancy could underestimate actual integrated fetal exposure in some instances. The skeletal weights of 18 fetuses, including those from mothers in this study as well as from other, stillborn monkeys obtained from the primate colony, are presented in Fig. 5 . Virtually all of the fetal skeletal mineral mass is accrued during the last trimester. Accordingly, the average concentration, during the third trimester, of lead in maternal blood attributable to bone was compared with the concentration of lead in the fetal skeleton (Fig. 6) . A significant correlation (r = 0.782, p < 0.05) was observed, with the near-term concentration of fetal bone lead attributable to maternal bone lead appearing to be about one and a half times the thirdtrimester contribution of maternal bone lead to maternal blood lead. Although the maternal blood lead values for CF145 were somewhat higher than those for the other leaddosed animals, there was judged to be insufficient evidence to exclude it from the group and therefore a linear fit was considered appropriate.
Biopsies from the tibias of the dam both prepregnancy and postpregnancy were analyzed for lead in trabecular and cortical bone. The total bone lead concentration was calculated using the ratio of 80% cortical/20% trabecular bone. The bone lead levels for the fetuses of monkeys CF131, CF158, CF162, and CF175 were 113 to 175% higher than those of the mothers, and the lead concentration in fetal bone of CF145 was 95% of the maternal value (Table 4) .
The mechanisms by which blood lead increases and is mobilized from bone during pregnancy are unclear, but current knowledge has been summarized by Silbergeld et al. (1993) and Rothenberg et al. (1994) . As the last authors acknowledge, attributing the reasons for blood lead increases in late pregnancy in human studies, have necessarily been tentative, given the inability to distinguish between endogenous (bone) and dietary/environmental sources to total blood lead. The present study in nonhuman primates is supportive of many of their suggestions that in many cases a combination of both increased bone lead and oral lead contributes to increases in total blood lead.
The proposed physiological changes during pregnancy that would be expected to affect blood lead concentrations are:
(a) In early pregnancy: increased maternal fluid volume (indicated by decreased hematocrit in humans), a gradual enlargement of organs (e.g., uterus, placenta, and mammaries), and enhanced metabolic activity. These would be expected to support evidence of a decrease in blood lead during early pregnancy.
(b) In late pregnancy: rapid growth of the fetal tissues, especially the fetal skeleton, with the resulting increased demand for calcium from maternal blood. Lead will become 0 10 20 30 Maternal Blood Lead from Bone (ug/lOOg) FIG. 6 . Relationship between the concentration of lead derived from maternal bone in maternal blood and in fetal bone. For each mother/fetus pair, the concentration of lead in fetal bone at term is plotted against the mean maternal blood concentration for bone-derived lead for the third trimester. The correlation coefficient, r = 0.782, which is significant at p < 0.05. incorporated into the fetal bone matrix along with calcium. The maternal response is likely to be a combination of (i) an increase in maternal calcium (and possibly lead) absorption; (ii) a decrease in calcium (and lead) elimination from the body; and (iii) an increased bone mineral resorption, resulting in bone calcium being mobilized to meet the demands of the fetal bone mineralization. In (iii), lead is also released from the bone matrix, thus contributing to elevated blood lead levels. Although the calcium content of food was replete (1%) in the case of the monkeys, it is likely that the dietary calcium status influences the relative contribution of endogenous/exogenous calcium to the fetus during pregnancy (King et al, 1992) .
In summary, through the use of sequential stable lead isotope tracers and TIMS analysis, it has been shown that lead in maternal bone becomes mobilized during pregnancy. A slight decrease in the contribution of lead returning from maternal bone to blood in early pregnancy is followed by an increase in the second and third trimesters. The rate of mobilization in late pregnancy can be as much as double that of the first trimester. Lead from maternal bone crosses the placenta and becomes incorporated into growing fetal bone, brain, and other tissues. Fetal bone lead concentrations in three of six animals were 150% or more of the concentrations in maternal bone on a dry weight basis.
In addition to allowing measurement of mobilization of lead during pregnancy, the sequential isotope method could be used to investigate bone lead release to blood during lactation, during menopause/postmenopausal osteoporosis, and also in disease states in which bone demineralization occurs.
